WeightWatchers' CEO embraced Ozempic. Now she's out of the company.
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
Sima Sistani, who embraced Ozempic, is out as CEO of WeightWatchers
WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two-year stint.
Lawmakers challenge drug company CEO over steep prices for Ozempic and Wegovy
Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes and obesity. But the drugs are extremely expensive, and the drugmaker’s CEO appeared on Capitol Hill Tuesday to face questions about why those prices are so high.
Novo Nordisk CEO grilled by Congress over Ozempic, Wegovy prices in US
For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their health.
Ozempic maker's CEO grilled over price of weight loss drugs
The CEO of the company that makes Ozempic faced a Bernie Sanders-led Senate hearing on Tuesday.
Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugs
Sen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
Ozempic CEO agrees to discuss lower prices for blockbuster weight loss drugs
Vt., on Tuesday extracted a meager commitment from Novo Nordisk CEO Lars Fruergaard Jørgensen to meet with pharmacy benefits managers to discuss lowering the cost of its blockbuster drugs Ozempic and Wegovy.
US Senator Sanders says middlemen won't punish Novo if it cuts weight-loss drug prices
U.S. Senator Bernie Sanders said on Tuesday he had commitments from the nation's top pharmacy benefit managers that they would expand coverage of Novo Nordisk's popular diabetes and weight-loss medicines if the company lowered the list prices.
Ozempic producer CEO in hot seat in Senate hearing over cost of drug
Senators grilled Novo Nordisk CEO Lars Jergensen Tuesday over the costs of Ozempic and similar weight loss drugs.
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.
U.S. Senator Sanders says pharmacy middlemen commit to expanding weight-loss drug coverage if prices cut
U.S. Senator Bernie Sanders said on Tuesday he had received commitments from all major pharmacy benefit managers they would expand coverage of Novo Nordisk's popular diabetes and weight-loss medicines if the company lowered their list prices.
Who’s Really Keeping Ozempic and Wegovy Prices So High?
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
Novo Nordisk CEO spars with lawmakers over Ozempic, Wegovy prices
The CEO of Novo Nordisk faced pointed questions about the cost of Ozempic and Wegovy on Capitol Hill Tuesday, as lawmakers ...
Sen. Bernie Sanders grills maker of Ozempic
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.
$50 Billion in Sales Make Ozempic and Wegovy Prices Tougher to Justify
Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...
Weight loss drugs like Ozempic and Wegovy are tremendously popular and effective. Patients should also be careful in using them
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
Ozempic and Wegovy drugmaker CEO defends high costs of drugs
Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the ...
Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...
Hitting the Pharmaceutical Jackpot With Novo’s Ozempic and Wegovy
Hi, it’s Bob in New York. I’ve been writing about drug costs for years, and Ozempic and Wegovy turn out to be in a unique ...
Women Are Losing More Weight on Ozempic—Scientists Are Finally Figuring Out Why
A new study published in JAMA Network Open contends that women may lose more weight on semaglutides like Ozempic than men. Here's why, according to doctors.